| abstract |
The present invention relates to an antibody, an antigen-binding fragment or a polypeptide which specifically binds to one or more proteins selected from the group consisting of APOBEC3A, FCGR3B, SERPINB5, NMU and PADI2 or each of the fragments thereof, or the APOBEC3A, FCGR3B, SERPINB5, NMU And PADI2, and a method for predicting lymph node metastasis in an early stage of gastric cancer using the same. 2. The method for diagnosing metastatic gastric cancer according to claim 1, wherein the at least one protein is selected from the group consisting of a probe, a primer set or a nucleotide. . |